<DOC>
	<DOC>NCT00385125</DOC>
	<brief_summary>Phase II study for treatment of patients with relapsed or primary refractory aggressive B- cell NHL and anthracycline chemotherapy pretreatment, who received or did not qualify for autologous stem cell transplantation.</brief_summary>
	<brief_title>Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL</brief_title>
	<detailed_description>Phase II study for treatment of patients with relapsed or primary refractory aggressive B- cell NHL and anthracycline chemotherapy pretreatment, who received or did not qualify for autologous stem cell transplantation. Aim is to find response rates and duration of combination chemotherapy (bendamustine/rituximab) in patients with relapsed or refractory CD 20 positive B cell NHL.</detailed_description>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Histologically proven high grade BNHL (CD 20 &gt;= 20 % positive) Age &gt;= 18 years At least one pretreatment with anthracycline polychemotherapy +/ radiatio: first relapse nad contraindication for aggressive salvage therapy e.g. high dose therapy with autologous stem cell transplantation second relapse (after aggressive salvage therapy) patient's refusal of aggressive salvage therapy in first relapse informed consent untreated patients pretreatment with bendamustine primary CNS lymphoma Karnofsky index &lt; 50 (except caused by lymphoma) HIV positive, hepatitis B or C serious concurrent disease noncompensated heart failure (&gt;=NYHA 3) noncompensated hypertension renal insufficiency (creatinine &gt; 2.0 mg/dl), not related to lymphoma hepatic insufficiency with transaminase values greater than 3fold of normal values and/or bilirubin levels &gt; 200 µmol/l, not related to lymphoma missing compliance respective incapability to comply (e.g.cerebral dysfunction pregnancy hematopoetic insufficiency not lymphoma related (leucocyte count &lt;= 2500/µl, granulocyte count &lt;= 1000/µl, platelet count &lt;= 80000/µl)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>relapsed</keyword>
	<keyword>refractory</keyword>
	<keyword>CD 20 positive</keyword>
</DOC>